Skip to main content
Top

International Journal of Clinical Oncology

Issue 7/2022

Including Invited Reviews on New trends in molecular targeted therapy for hepatocellular carcinoma

Content (15 Articles)

NSCLC Review Article

Prognostic value of myosteatosis in patients with lung cancer: a systematic review and meta-analysis

Shaofang Feng, Huiwen Mu, Rong Hou, Yunxin Liu, Jianjun Zou, Zheng Zhao, Yubing Zhu

NSCLC Original Article

Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801

Shinobu Hosokawa, Eiki Ichihara, Daijiro Harada, Shoichi Kuyama, Koji Inoue, Kenichi Gemba, Hirohisa Ichikawa, Yuka Kato, Naohiro Oda, Isao Oze, Tomoki Tamura, Toshiyuki Kozuki, Takahiro Umeno, Toshio Kubo, Katsuyuki Hotta, Akihiro Bessho, Yoshinobu Maeda, Katsuyuki Kiura

Breast Cancer Original Article

Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer

Hongjuan Zheng, Chenyang Ge, Haiping Lin, Lunpo Wu, Qinghua Wang, Shishi Zhou, Wanfen Tang, Xia Zhang, Xiayun Jin, Xifeng Xu, Zhongwu Hong, Jianfei Fu, Jinlin Du

Open Access Gastric Cancer Original Article

Real-world effectiveness of third- or later-line treatment in Japanese patients with HER2-positive, unresectable, recurrent or metastatic gastric cancer: a retrospective observational study

Daisuke Sakai, Takeshi Omori, Soichi Fumita, Junya Fujita, Ryohei Kawabata, Jin Matsuyama, Hisateru Yasui, Motohiro Hirao, Tomono Kawase, Kentaro Kishi, Yoshiki Taniguchi, Yasuhiro Miyazaki, Junji Kawada, Hironaga Satake, Tomoko Miura, Akimitsu Miyake, Yukinori Kurokawa, Makoto Yamasaki, Tomomi Yamada, Taroh Satoh, Hidetoshi Eguchi, Yuichiro Doki

Diarrhea Original Article

Efficacy and safety of regorafenib in Japanese patients with advanced gastrointestinal stromal tumors

Ryugo Teranishi, Tsuyoshi Takahashi, Toshirou Nishida, Seiichi Hirota, Yukinori Kurokawa, Takuro Saito, Kazuyoshi Yamamoto, Kotaro Yamashita, Koji Tanaka, Tomoki Makino, Masaaki Motoori, Takeshi Omori, Kiyokazu Nakajima, Hidetoshi Eguchi, Yuichiro Doki

Establishment and validation of a nomogram for predicting potential lateral pelvic lymph node metastasis in low rectal cancer

Atsuhiko Sumii, Koya Hida, Yoshiharu Sakai, Nobuaki Hoshino, Daisuke Nishizaki, Tomonori Akagi, Meiki Fukuda, Tomohiro Yamaguchi, Ichiro Takemasa, Takuya Tokunaga, Jun Watanabe, Masahiko Watanabe

Open Access Colorectal Cancer Original Article

Performance of Idylla™ RAS-BRAF mutation test for formalin-fixed paraffin-embedded tissues of colorectal cancer

Yusuke Makutani, Kazuko Sakai, Masahiro Yamada, Toshiaki Wada, Takaaki Chikugo, Takao Satou, Yoko Iwasa, Hidekazu Yamamoto, Marco A. de Velasco, Kazuto Nishio, Junichiro Kawamura

Metastasis Original Article

The impact of S-1 for the patient with lymph nodal metastasis biliary tract cancer as adjuvant chemotherapy: a multicenter database analysis

Ryoga Hamura, Koichiro Haruki, Tomohiko Taniai, Mitsuru Yanagaki, Yoshihiro Shirai, Kenei Furukawa, Teruyuki Usuba, Shuichi Fujioka, Tomoyoshi Okamoto, Yukio Nakabayashi, Tadashi Uwagawa, Toru Ikegami

Opioids Original Article

Efficacy of EUS-guided celiac plexus neurolysis in combination with EUS-guided celiac ganglia neurolysis for pancreatic cancer-associated pain: a multicenter prospective trial

Ken Kamata, Makiko Kinoshita, Ikuharu Kinoshita, Hajime Imai, Takeshi Ogura, Hisakazu Matsumoto, Kosuke Minaga, Yasutaka Chiba, Mamoru Takenaka, Masatoshi Kudo, Masayuki Kitano

Mesothelioma Original Article

What has changed in malignant mesothelioma between 1990 and 2019? A time- series analyses in Turkey

Selma Metintas, Guntulu Ak, Emine Dundar, Muzaffer Metintas

Metastasis Original Article

Spread of lymph node metastasis and adjuvant therapy for distal cholangiocarcinoma

Hiroshi Kurahara, Yuko Mataki, Tetsuya Idichi, Yota Kawasaki, Shinichiro Mori, Ken Sasaki, Takaaki Arigami, Akihiro Nakajo, Yoshihiko Fukukura, Michiyo Higashi, Takao Ohtsuka

Open Access Acute Myeloid Leukemia Original Article

Overexpression of miR-17 predicts adverse prognosis and disease recurrence for acute myeloid leukemia

Yang Cao, Yue Liu, Limei Shang, Huijuan Chen, Yanhua Yue, Weimin Dong, Yanting Guo, Haonan Yang, Xiaojun Yang, Yan Liu, Weiying Gu, Xiaoying Zhang

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine